A rapid and efficient red-light-activated Cre recombinase system for genome engineering in mammalian cells and transgenic mice
文献类型:期刊论文
| 作者 | Zhou, Yang5,6,7,8; Wei, Yu6,7; Yin, Jianli6,7,8,9; Kong, Deqiang6,7; Li, Wenjun1; Wang, Xinyi5,6,7; Yao, Yining4; Huang, Qin6,7; Li, Lei6,7; Liu, Mengyao6,7 |
| 刊名 | NUCLEIC ACIDS RESEARCH
![]() |
| 出版日期 | 2025-08-28 |
| 卷号 | 53期号:15页码:18 |
| ISSN号 | 0305-1048 |
| DOI | 10.1093/nar/gkaf758 |
| 通讯作者 | Ye, Haifeng(hfye@bio.ecnu.edu.cn) |
| 英文摘要 | The Cre-loxP recombination system enables precise genome engineering; however, existing photoactivatable Cre tools suffer from several limitations, including low DNA recombination efficiency, background activation, slow activation kinetics, and poor tissue penetration. Here, we present REDMAPCre, a red-light-controlled split-Cre system based on the Delta PhyA/FHY1 interaction. REDMAPCre enables rapid activation (1-s illumination) and achieves an 85-fold increase in reporter expression over background levels. We demonstrate its efficient regulation of DNA recombination in mammalian cells and mice, as well as its compatibility with other inducible recombinase systems for Boolean logic-gated DNA recombination. Using a single-vector adeno-associated virus delivery system, we successfully induced REDMAPCre-mediated DNA recombination in mice. Furthermore, we generated a REDMAPCre transgenic mouse line and validated its efficient, light-dependent recombination across multiple organs. To explore its functional applications, REDMAPCre transgenic mice were crossed with isogenic Cre-dependent reporter mice, enabling optogenetic induction of insulin resistance and hepatic lipid accumulation via Cre-dependent overexpression of ubiquitin-like with PHD and RING finger domains 1 (UHRF1), as well as targeted cell ablation through diphtheria toxin fragment A expression. Collectively, REDMAPCre provides a powerful tool for achieving remote control of recombination and facilitating functional genetic studies in living systems. |
| WOS关键词 | SPATIOTEMPORAL CONTROL ; DNA ; INHIBITION ; EXPRESSION ; TAMOXIFEN ; BRAIN |
| WOS研究方向 | Biochemistry & Molecular Biology |
| 语种 | 英语 |
| WOS记录号 | WOS:001548837100001 |
| 资助机构 | National Natural Science Foundation of China ; ECNU Multifunctional Platform for Innovation |
| 源URL | [http://ir.yic.ac.cn/handle/133337/41034] ![]() |
| 专题 | 海岸带生物学与生物资源利用重点实验室 |
| 通讯作者 | Ye, Haifeng |
| 作者单位 | 1.Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai 264003, Peoples R China 2.Chinese Univ Hong Kong, Dept Biomed Engn, Sha Tin, Hong Kong 999077, Peoples R China 3.Beijing Life Sci Acad, Yingcai South 1st St, Beijing 102209, Peoples R China 4.East China Normal Univ, Sch Chem & Mol Engn, Dept Chem, Shanghai 200241, Peoples R China 5.East China Normal Univ, Wuhu Hosp, Hlth Sci Ctr, Wuhu 241001, Peoples R China 6.East China Normal Univ, Shanghai Frontiers Sci Ctr Genome Editing & Cell T, Inst Biomed Sci,Shanghai Key Lab Regulatory Biol, Shanghai Acad Nat Sci SANS,Biomed Synthet Biol Res, Shanghai 200241, Peoples R China 7.East China Normal Univ, Shanghai Acad Nat Sci SANS, Sch Life Sci, Shanghai 200241, Peoples R China 8.East China Normal Univ, Chongqing Inst, Chongqing Key Lab Precis Opt, Chongqing 401120, Peoples R China 9.East China Normal Univ & Fengxian Dist Cent Hosp, Joint Ctr Translat Med, Sch Life Sci, Shanghai 201499, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhou, Yang,Wei, Yu,Yin, Jianli,et al. A rapid and efficient red-light-activated Cre recombinase system for genome engineering in mammalian cells and transgenic mice[J]. NUCLEIC ACIDS RESEARCH,2025,53(15):18. |
| APA | Zhou, Yang.,Wei, Yu.,Yin, Jianli.,Kong, Deqiang.,Li, Wenjun.,...&Ye, Haifeng.(2025).A rapid and efficient red-light-activated Cre recombinase system for genome engineering in mammalian cells and transgenic mice.NUCLEIC ACIDS RESEARCH,53(15),18. |
| MLA | Zhou, Yang,et al."A rapid and efficient red-light-activated Cre recombinase system for genome engineering in mammalian cells and transgenic mice".NUCLEIC ACIDS RESEARCH 53.15(2025):18. |
入库方式: OAI收割
来源:烟台海岸带研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

